convergentvc.comCrawled Oct 25, 2026
Predictive agriculture, using machine learning to track and quantify soil carbon data in real time and field conditions ahead of time
FIGUR8 discusses challenges in objectively assessing worker recovery progress using data.
Biotia, a genomics and AI-powered company fighting infectious diseases, raised an $8 million Series A round led by OCA Ventures, with participation from Continuum Health Ventures, Phoenix Venture Partners, SeedtoB Capital, SK Square Americas, Digital-Dx Ventures, and others.
Braga Fresh and climate tech start-up Agrology were recently honored with the IFPA’s Science and Technology Circle of Excellence award for achievements measuring soil health and quantifying regenerative ag outcomes.
Convergent Ventures is a fund specializing in healthcare and sustainability, staffed by experts who have founded companies in those sectors.
The page highlights the interconnectedness of health and environment, showing how clean air, water, and soil impact health, and how health improvements affect the environment.
Convergent Ventures builds trust with founders through expertise, humility, and fairness, offering introductions, strategy advice, and fundraising support.
The company’s team includes founders, scientists, and physicians with decades of experience investing in early-stage science-driven health and sustainability ventures.
Convergent Ventures LLC 580 California Street, 12th floor San Francisco CA 94104
Biotia secures an oversubscribed $9 million funding round to advance its BIOTIA-ID Urine Test, which detects recurrent and complicated urinary tract infections (UTIs) with high accuracy. The company expands its board to support growth in infectious disease diagnostics for women’s health and orthopedics. The test is already available nationwide to physicians and patients.
Oct 2026PR NewswireNews article